Hob Biotech Group Stock Revenue
| 688656 Stock | 111.45 1.35 1.23% |
HOB Biotech Group fundamentals help investors to digest information that contributes to HOB Biotech's financial success or failures. It also enables traders to predict the movement of HOB Stock. The fundamental analysis module provides a way to measure HOB Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to HOB Biotech stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 394.4 M | 271.3 M |
HOB | Revenue |
HOB Biotech Group Company Revenue Analysis
HOB Biotech's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current HOB Biotech Revenue | 394.41 M |
Most of HOB Biotech's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, HOB Biotech Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
HOB Total Revenue
Total Revenue |
|
Based on the latest financial disclosure, HOB Biotech Group reported 394.41 M of revenue. This is 94.83% lower than that of the Health Care Equipment & Supplies sector and 84.54% lower than that of the Health Care industry. The revenue for all China stocks is 95.82% higher than that of the company.
HOB Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses HOB Biotech's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of HOB Biotech could also be used in its relative valuation, which is a method of valuing HOB Biotech by comparing valuation metrics of similar companies.HOB Biotech is currently under evaluation in revenue category among its peers.
HOB Fundamentals
| Return On Equity | 0.0439 | ||||
| Return On Asset | 0.0266 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 6.95 B | ||||
| Shares Outstanding | 63.06 M | ||||
| Shares Owned By Insiders | 77.69 % | ||||
| Shares Owned By Institutions | 3.10 % | ||||
| Price To Book | 8.61 X | ||||
| Price To Sales | 17.44 X | ||||
| Revenue | 394.41 M | ||||
| Gross Profit | 320.16 M | ||||
| EBITDA | 78.62 M | ||||
| Net Income | 47.92 M | ||||
| Total Debt | 54.83 M | ||||
| Book Value Per Share | 12.95 X | ||||
| Cash Flow From Operations | 102.69 M | ||||
| Earnings Per Share | 0.56 X | ||||
| Number Of Employees | 550 | ||||
| Beta | 0.21 | ||||
| Market Capitalization | 7 B | ||||
| Total Asset | 949.26 M | ||||
| Retained Earnings | 162.13 M | ||||
| Working Capital | 192.46 M | ||||
| Annual Yield | 0 % | ||||
| Net Asset | 949.26 M | ||||
| Last Dividend Paid | 0.4 |
About HOB Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze HOB Biotech Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of HOB Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of HOB Biotech Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in HOB Stock
HOB Biotech financial ratios help investors to determine whether HOB Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HOB with respect to the benefits of owning HOB Biotech security.